Innovative Imaging Solutions Median Technologies offers advanced AI-powered medical imaging solutions specifically tailored for oncology clinical trials and cancer diagnosis, presenting a strong opportunity to partner with pharmaceutical companies and healthcare providers aiming to enhance diagnostic accuracy and treatment efficacy.

Strategic Industry Presence With active participation in major industry events such as ASCO 2025 and upcoming presentations at healthcare conferences, Median Technologies demonstrates strong engagement and visibility within the oncology and medical imaging sectors, facilitating connections with key decision-makers and potential clients.

Robust Financials and Funding Having secured significant funding of €21.6 million and revenue estimates between $50 million and $100 million, the company is well-positioned for expansion and partnership opportunities within the medical imaging and clinical trial markets.

Regulatory Milestones and Collaborations Recent achievements include FDA interaction completion for iBiopsy and the establishment of a Clinical Advisory Board, indicating regulatory progress and credibility that can accelerate sales opportunities with biopharmaceutical firms seeking approved diagnostic tools.

Expanding Service Offerings The launch of a new business unit providing AI-based decision-support tools for oncology trial sponsors suggests an increased demand for integrated, innovative solutions, creating sales potential across clinical research organizations and healthcare institutions seeking advanced imaging technologies.